Birchview Capital as of Dec. 31, 2020
Portfolio Holdings for Birchview Capital
Birchview Capital holds 48 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 28.4 | $49M | 794k | 62.03 | |
Biodesix (BDSX) | 12.8 | $22M | 1.1M | 20.16 | |
Accelr8 Technology | 9.6 | $17M | 2.2M | 7.58 | |
Quidel Corporation | 6.1 | $11M | 59k | 179.64 | |
Neurocrine Biosciences (NBIX) | 4.4 | $7.7M | 80k | 95.85 | |
Foghorn Therapeutics (FHTX) | 3.7 | $6.4M | 314k | 20.27 | |
Aspira Womens Health | 3.2 | $5.6M | 840k | 6.69 | |
ACADIA Pharmaceuticals (ACAD) | 3.1 | $5.5M | 102k | 53.46 | |
Albireo Pharma | 2.0 | $3.5M | 92k | 37.51 | |
Oxford Immunotec Global | 1.7 | $3.0M | 170k | 17.46 | |
Biogen Idec (BIIB) | 1.7 | $3.0M | 12k | 244.88 | |
Karyopharm Therapeutics (KPTI) | 1.7 | $2.9M | 188k | 15.48 | |
United Therapeutics Corporation (UTHR) | 1.6 | $2.7M | 18k | 151.78 | |
Bluebird Bio (BLUE) | 1.5 | $2.7M | 62k | 43.27 | |
Acceleron Pharma | 1.4 | $2.4M | 19k | 127.95 | |
Masimo Corporation (MASI) | 1.2 | $2.1M | 8.0k | 268.38 | |
Chemocentryx | 1.1 | $1.9M | 30k | 61.93 | |
Arena Pharmaceuticals | 1.0 | $1.7M | 22k | 76.82 | |
Soleno Therapeutics | 0.9 | $1.6M | 827k | 1.93 | |
Amarin Corp Spons Adr New (AMRN) | 0.8 | $1.5M | 300k | 4.89 | |
Progenity | 0.8 | $1.3M | 250k | 5.31 | |
Corcept Therapeutics Incorporated (CORT) | 0.8 | $1.3M | 50k | 26.16 | |
Arvinas Ord (ARVN) | 0.7 | $1.3M | 15k | 84.93 | |
Stoke Therapeutics (STOK) | 0.7 | $1.2M | 20k | 61.95 | |
Harrow Health (HROW) | 0.7 | $1.2M | 180k | 6.86 | |
ImmunoGen | 0.7 | $1.2M | 190k | 6.45 | |
Equitrans Midstream Corp (ETRN) | 0.6 | $1.1M | 133k | 8.04 | |
Vanda Pharmaceuticals (VNDA) | 0.6 | $1.1M | 80k | 13.14 | |
Contrafect | 0.6 | $1.0M | 200k | 5.05 | |
Amicus Therapeutics (FOLD) | 0.5 | $877k | 38k | 23.08 | |
Biohaven Pharmaceutical Holding | 0.5 | $857k | 10k | 85.70 | |
Tg Therapeutics (TGTX) | 0.4 | $780k | 15k | 52.00 | |
Bmy Cvr Rts 03/31/21 Right | 0.4 | $763k | 1.1M | 0.69 | |
G1 Therapeutics (GTHX) | 0.4 | $720k | 40k | 18.00 | |
Progyny (PGNY) | 0.4 | $636k | 15k | 42.40 | |
Continental Resources | 0.4 | $629k | 39k | 16.30 | |
Inari Medical Ord (NARI) | 0.4 | $611k | 7.0k | 87.29 | |
Kalvista Pharmaceuticals (KALV) | 0.3 | $570k | 30k | 19.00 | |
Translate Bio | 0.3 | $553k | 30k | 18.43 | |
Xencor (XNCR) | 0.3 | $537k | 12k | 43.66 | |
Encana Corporation (OVV) | 0.3 | $493k | 34k | 14.35 | |
Apellis Pharmaceuticals (APLS) | 0.3 | $458k | 8.0k | 57.25 | |
Pioneer Natural Resources (PXD) | 0.2 | $433k | 3.8k | 113.95 | |
Odonate Therapeutics Ord | 0.2 | $384k | 20k | 19.20 | |
Inflarx Nv (IFRX) | 0.2 | $352k | 70k | 5.03 | |
Dicerna Pharmaceuticals | 0.1 | $220k | 10k | 22.00 | |
BioCryst Pharmaceuticals (BCRX) | 0.1 | $149k | 20k | 7.45 | |
Yield10 Bioscience | 0.1 | $110k | 19k | 5.80 |